Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0423716 (
Neuropathic pain
)
1,417
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Neuropathic pain
affects 1-10% of the general population and is caused by a lesion or disease of the somatosensory nervous system. Spinal cord stimulation (SCS), a method where implanted electrodes stimulate the spinal cord, has been successfully used to treat drug-resistant neuropathic pain, but the mechanism of action is largely unknown. Studies show that SCS changes the protein levels in
CSF
(cerebrospinal fluid) of pain patients. Several neurological conditions have been shown to alter the elemental composition of
CSF
. Therefore changes in the levels of ions and trace elements in the
CSF
may correspond to SCS use. This study used ICP-MS (Inductively coupled plasma mass spectrometry) and ICP-AES (Inductively coupled plasma atomic emission spectroscopy) to quantify 10 elements in
CSF
from chronic neuropathic pain patients using SCS. The element concentrations in
CSF
from patients with SCS treatment on/off, were measured. No effect on the element concentrations in
CSF
from treatment with SCS could be detected. Also, the elemental concentrations in pooled
CSF
from patients without chronic neuropathic pain was determined and compared to the patients using SCS. The concentration of the elements Ca, Sr, Na, K, P, Mg and Ti were, significantly higher in patients compared to the
CSF
-control.
...
PMID:Quantification of 10 elements in human cerebrospinal fluid from chronic pain patients with and without spinal cord stimulation. 2747 26